Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Return on Assets (2016 - 2018)

Armata Pharmaceuticals' Return on Assets history spans 5 years, with the latest figure at 0.36% for Q3 2018.

  • For Q3 2018, Return on Assets rose 63.0% year-over-year to 0.36%; the TTM value through Sep 2018 reached 0.36%, up 63.0%, while the annual FY2017 figure was 0.38%, N/A changed from the prior year.
  • Return on Assets for Q3 2018 was 0.36% at Armata Pharmaceuticals, down from 0.16% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.16% in Q2 2018 and bottomed at 1.08% in Q2 2017.
  • The 5-year median for Return on Assets is 0.44% (2017), against an average of 0.51%.
  • The largest annual shift saw Return on Assets tumbled -75bps in 2017 before it skyrocketed 93bps in 2018.
  • A 5-year view of Return on Assets shows it stood at 0.76% in 2014, then skyrocketed by 61bps to 0.29% in 2015, then tumbled by -64bps to 0.48% in 2016, then rose by 4bps to 0.46% in 2017, then grew by 22bps to 0.36% in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Return on Assets are 0.36% (Q3 2018), 0.16% (Q2 2018), and 0.43% (Q1 2018).